IPO > IPO details

< Back

Akums Drugs and Pharmaceuticals Limited

Main Board

Issue Price

₹ 646-₹ 679

per equity share

Issue Size

1.52 crores

equity share

Face Value

₹ 2

per equity share

Market Lot

22

equity share

Please note

Listing at NSE

Akums Drugs and Pharmaceuticals Limited

Important Dates

IPO Open Date

30 Jul 2024

IPO Close Date

01 Aug 2024

Allotment Date

02 Aug 2024

Initiation of Refunds

05 Aug 2024

Credit of Shares to Demat Account

05 Aug 2024

IPO Listing Date

06 Aug 2024

UPI Mandate Expiry Date

01 Aug 2024

IPO Details

Akums Drugs and Pharmaceuticals is open for subscription from Tuesday, July 30, 2024, and closing on Thursday, August 1, 2024. The price band for this IPO is set to Rs 646 – Rs 679 per share.  Akums Drugs and Pharmaceuticals is a 100% book-built public issue. The company is offering a fresh issue of 10.01 crore of equity shares amounting up to Rs 680 crore and an offer for sale of 1.73 crore of equity shares amounting up to Rs 1,262.83 crore, this aggregates to total size of 2.73 crore of equity shares amounting up to Rs 1,856.74 crore. The allotment for this new IPO is expected to be finalised on Friday, August 2, 2024. This IPO will be listed on the NSE and BSE exchanges on Tuesday, August 6, 2024. The minimum and maximum lot size set for the retail category is 1 lot, i.e., 22 shares and 13 lots, i.e., 286 shares, respectively. For retail investors, the minimum and maximum investment amount required is Rs 14,938 and Rs 1,94,194, respectively. The IPO is managed by ICICI Securities Limited, Axis Bank Limited, Citigroup Global Markets India Private Limited and Ambit Private Limited, which are the lead managers. The company has appointed Link Intime India Private Limited as the registrar for the issue.

Seize the deal, apply for IPO today!

Apply for IPO

About Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited, established in 2004, is a pharmaceutical CDMO providing a wide range of pharma products and services in India and overseas. The company offers end-to-end solutions for product development, manufacturing, R&D of formulations, regulatory dossier preparation, and other testing services. Akums also manufactures and sells branded drugs and APIs. Akums produce various dosage forms, including tablets, capsules, liquid medicines, and more, totalling 4,025 commercialised formulations in over 60 dosage forms. In FY 2023, the company manufactured formulations for 26 of the top 30 Indian pharmaceutical companies. Akums operates 10 manufacturing units with a combined production capacity of 49.21 billion units annually and plans to expand with two additional units by FY 2025. As of September 30, 2023, Akums employed 16,463 people.

Parent Organisation

Founded

2004

Managing Director

Sanjeev Jain, Sandeep Jain, and Akums Master Trust

IPO Objectives

The net proceeds are proposed by the firm to be utilised in several. A portion of the proceeds will be utilising to the repayment or prepayment of indebtedness for both the company and its subsidiaries. Funds will be allocated to meet incremental working capital requirements, ensuring smooth and efficient operations. The company also plans to pursue inorganic growth through strategic acquisitions, which will enhance its market presence and capabilities. Lastly, a part of the proceeds will be used for general corporate purposes.

How to apply for IPO

  • Login to your Bigul account and select the issue in the current IPO section
  • Enter the number of lots and price at which you wish to apply for
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
  • You will receive a mandate notification to block funds in your UPI app
  • Approve the mandate request on your UPI and funds will be blocked
Close

Let's Open Free Demat Account